SLC14A1 and renal cell carcinoma: Fifthly, the involvement of SLC14A1 in hypoxia-driven renal cell carcinoma progression via mitochondrial-dependent pathways implies that oxygen-targeted therapeutic approaches could potentially improve treatment outcomes for this malignancy.